When Cancer Rxs Team Up
Sometimes it takes two. Two breast cancer medications, that is.
Breast Cancer Survivors Battling Brittle Bones
Breast cancer survivors can have ongoing health challenges after they’ve beaten "The Big C." Many are on medications that block estrogen, the hormone that drives most breast cancers. These medicines also increase the risk of osteoporosis (brittle bones) and increase the risk of fractures.
Which Cancer Survivors Need to Keep Blocking
Medications that block estrogen can be life savers for some breast cancer survivors. But does this approach help all breast cancer survivors?
1 in 4 Women Skips Breast Cancer Therapy
The majority of breast cancers are fed by the hormones estrogen and progesterone. That’s why women with hormone-sensitive breast cancer are prescribed medicines to block these hormones. But a good portion of women may be skipping the therapy.
Weight May Not Affect Breast Cancer Survival
We’ve been told time and again that fat kills. Being overweight or obese definitely adds to our risks of developing chronic diseases including cancer. A new study finds, though, that it doesn’t appear to impact cancer survival.
A Breast Cancer Elf?
Here’s an intriguing thought. What if we could reprogram cancer so it responds to treatment? That’s exactly what breast cancer experts are exploring.
Can a Single Gene Defeat Tamoxifen Treatment?
Not all women respond to a common breast cancer drug called tamoxifen . Not to worry–these women can now be identified and switched to another medication before the disease turns deadly.
Femara Superior to Tamoxifen Study Shows
For years, tamoxifen has been the gold standard for keeping breast cancer from reappearing. Updated research shows another medication known as an aromatase inhibitor is even more effective for post-menopausal women.
Male Hormones Drive Some Female Breast Cancers
Most breast cancers are fueled by the female hormone estrogen. In an interesting twist, scientists have discovered that a male hormone ignites breast tumor growth in some women.